Table 14b. Survival for more than 12, 24, and 36 months after an AIDS diagnosis during 2000–2004, by selected characteristics—United States and 5 U.S. dependent areas

	No. of persons	Proportion survived (in months)
		>12	>24	>36
Age at diagnosis (yr)
<13	507	0.92	0.91	0.90
13–14	346	0.97	0.96	0.93
15–19	1,507	0.97	0.94	0.93
20–24	7,390	0.94	0.92	0.89
25–29	16,293	0.93	0.90	0.88
30–34	29,603	0.92	0.89	0.86
35–39	41,736	0.90	0.87	0.84
40–44	38,513	0.88	0.84	0.81
45–49	27,669	0.85	0.81	0.78
50–54	16,626	0.82	0.78	0.74
55–59	8,383	0.78	0.74	0.70
60–64	4,373	0.74	0.69	0.65
≥65	3,842	0.65	0.59	0.54
Race/ethnicity
American Indian/Alaska Native	864	0.86	0.81	0.78
Asiana	1,808	0.90	0.88	0.87
Black/African American	96,469	0.87	0.83	0.80
Hispanic/Latinob	39,984	0.87	0.84	0.82
Native Hawaiian/Other Pacific Islander	192	0.90	0.85	0.83
White	55,641	0.89	0.86	0.83
Multiple races	1,795	0.92	0.88	0.84
Transmission category
Male adult or adolescent
Male-to-male sexual contact	68,841	0.91	0.88	0.86
Injection drug use	23,580	0.84	0.79	0.75
Male-to-male sexual contact and injection drug use	9,839	0.91	0.87	0.84
Heterosexual contactc	16,471	0.88	0.85	0.82
Otherd	25,642	0.81	0.78	0.75
Subtotal	144,373	0.88	0.84	0.82
Female adult or adolescent
Injection drug use	12,039	0.86	0.80	0.75
Heterosexual contactc	25,540	0.90	0.87	0.84
Otherd	14,329	0.86	0.81	0.79
Subtotal	51,908	0.88	0.84	0.80
Child (<13 yrs at diagnosis)
Perinatal	475	0.92	0.91	0.91
Othere	32	0.88	0.81	0.81
Subtotal	507	0.92	0.91	0.90
Region of residence
Northeast	53,076	0.89	0.86	0.83
Midwest	20,313	0.89	0.86	0.84
South	85,701	0.87	0.83	0.79
West	32,323	0.90	0.87	0.85
U.S. dependent areas	5,375	0.71	0.68	0.65
Year of diagnosis
2000	40,317	0.87	0.83	0.79
2001	39,276	0.87	0.83	0.80
2002	39,178	0.88	0.84	0.81
2003	39,749	0.89	0.85	0.83
2004	38,268	0.89	0.86	0.83
Totalf	196,788	0.88	0.84	0.81

Note. Excludes persons whose month of diagnosis or month of death is unknown.

^a Includes Asian/Pacific Islander legacy cases (see Technical Notes).

^b Hispanics/Latinos can be of any race.

^c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.

^d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.

^e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.

^f Includes persons of unknown race/ethnicity.